Mankind Pharma shares rise 2% on robust Q4 results
The newly listed pharma company reported 52% growth in profit at ₹294 crore, while revenue from operations rose 19% to ₹2,053 crore in Q4FY23.
pharma
May 2023
April 2023
March 2023
This pharma stock surges 10% post 33% fall in two sessions
The stock has fallen nearly 27% since May 18, 2023, after the pharma company released its fourth-quarter results
Mankind Pharma shares nosedive 5% on report of I-T raid
The pharma stock, which made its market debut on May 9, has fallen as much as 9% in the last two sessions.
Mankind Pharma shares plunge 7% on day 2 after strong debut
Despite today’s fall, Mankind Pharma shares trade 23.5% higher than its initial public offering (IPO) price of ₹1,080 per share
Despite muted response from retail investors, Mankind Pharma IPO subscribed 15 times
The portion reserved for QIBs was subscribed over 49 times, while quota for NIIs and retail investors were booked 3.8% times and 0.9 times, respectively.
Mankind Pharma IPO opens today; raises ₹1,298 cr from anchor investors
The pharma company has raised ₹1,297.90 crore by allotting 1.2 crore equity shares at upper end of price band at ₹1,080 per share to 77 anchor investors.
Zydus Lifesciences gets USFDA nod for osteoporosis drug; stock hits 52-week high
The USFDA has allowed Zydus to manufacture and market Estradiol Transdermal System USP in the U.S; the drug will be produced at the group’s facility in Moraiya, Ahmedabad.
Mankind Pharma sets price band for ₹4,326 cr IPO at ₹1026-1080 per share
The IPO of the pharma company will open for subscription on April 25 and close on April 27.
Pharma’s R&D Ambitions Go Global
India’s life sciences R&D is undergoing a sea change. Given the huge risks and investments involved, can India taste success in innovative medicine, therapy and diagnostic tools?
Lupin shares dip 4% on US FDA observations for Pithampur unit
The U.S. drug regulator has issued Form 483 with ten observations for Lupin’s Pithampur unit-2 manufacturing facility.
